107 related articles for article (PubMed ID: 7169987)
1. Bone metabolism in chronic renal failure.
Evans RA; Flynn J; Dunstan CR; George CR; McDonnell GD
Miner Electrolyte Metab; 1982 Apr; 7(4):207-18. PubMed ID: 7169987
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bone histology in end-stage renal failure.
Evans RA; Flynn J; Dunstan CR; George CR
Prog Biochem Pharmacol; 1980; 17():236-41. PubMed ID: 7208502
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
[TBL] [Abstract][Full Text] [Related]
4. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
[TBL] [Abstract][Full Text] [Related]
5. Bone aluminum and histomorphometric features of renal osteodystrophy.
Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
[TBL] [Abstract][Full Text] [Related]
6. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
[TBL] [Abstract][Full Text] [Related]
7. Bone histology in young adult osteoporosis.
Hills E; Dunstan CR; Wong SY; Evans RA
J Clin Pathol; 1989 Apr; 42(4):391-7. PubMed ID: 2715352
[TBL] [Abstract][Full Text] [Related]
8. [Effect of strontium on bone metabolism in hemodialysis patients].
Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure.
Furlong T; Chan YL; Cornish C; McDowall D; Mahony J; Clifton-Bligh P
Nephron; 1991; 58(2):138-43. PubMed ID: 1865968
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
Rojas E; Carlini RG; Clesca P; Arminio A; Suniaga O; De Elguezabal K; Weisinger JR; Hruska KA; Bellorin-Font E
Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-independent osteoclastic resorptive bone disease: a new variant of adynamic bone disease in haemodialysis patients.
Gal-Moscovici A; Popovtzer MM
Nephrol Dial Transplant; 2002 Apr; 17(4):620-4. PubMed ID: 11917055
[TBL] [Abstract][Full Text] [Related]
12. Development of renal bone disease.
Ferreira A
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():2-12. PubMed ID: 16884393
[TBL] [Abstract][Full Text] [Related]
13. Low turnover bone disease is the more common form of bone disease in CAPD patients.
Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
[TBL] [Abstract][Full Text] [Related]
14. Acidosis-induced osteomalacia: metabolic studies and skeletal histomorphometry.
Phelps KR; Einhorn TA; Vigorita VJ; Lieberman RL; Uribarri J
Bone; 1986; 7(3):171-9. PubMed ID: 3768194
[TBL] [Abstract][Full Text] [Related]
15. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
Lafage MH; Combe C; Fournier A; Aparicio M
Kidney Int; 1992 Nov; 42(5):1217-25. PubMed ID: 1453606
[TBL] [Abstract][Full Text] [Related]
16. Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.
Weinstein RS
Calcif Tissue Int; 1982 Jan; 34(1):16-20. PubMed ID: 6802455
[TBL] [Abstract][Full Text] [Related]
17. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
Parfitt AM
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
[TBL] [Abstract][Full Text] [Related]
18. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
[TBL] [Abstract][Full Text] [Related]
19. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
Malluche HH; Goldstein DA; Massry SG
J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
